You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 22, 2024

Investigational Drug Information for ABBV-951


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug ABBV-951?

ABBV-951 is an investigational drug.

There have been 7 clinical trials for ABBV-951. The most recent clinical trial was a Phase 3 trial, which was initiated on February 18th 2021.

The most common disease conditions in clinical trials are Parkinson Disease and [disabled in preview]. The leading clinical trial sponsors are AbbVie and [disabled in preview].

There is one US patent protecting this investigational drug and two hundred and eighty-six international patents.

Recent Clinical Trials for ABBV-951
TitleSponsorPhase
Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's DiseaseAbbViePhase 1
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's DiseaseAbbViePhase 3
Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's DiseaseAbbViePhase 3

See all ABBV-951 clinical trials

Clinical Trial Summary for ABBV-951

Top disease conditions for ABBV-951
Top clinical trial sponsors for ABBV-951

See all ABBV-951 clinical trials

International Patents for ABBV-951

Drugname Country Document Number Estimated Expiration Related US Patent
ABBV-951 Argentina AR102389 2034-10-21 ⤷  Try a Trial
ABBV-951 Australia AU2015335941 2034-10-21 ⤷  Try a Trial
ABBV-951 Australia AU2021201414 2034-10-21 ⤷  Try a Trial
ABBV-951 Brazil BR112017008198 2034-10-21 ⤷  Try a Trial
ABBV-951 Canada CA2965379 2034-10-21 ⤷  Try a Trial
ABBV-951 China CN107206013 2034-10-21 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.